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Abstract
Background
A large proportion of neonates are treated for presumed bacterial sepsis with broad spectrum
antibiotics even though their blood cultures subsequently show no growth. This study aimed to
investigate PCR-based methods to identify pathogens not detected by conventional culture.
Methods
Whole blood samples of 208 neonates with suspected early onset sepsis were tested using
a panel of multiplexed bacterial PCRs targeting Streptococcus pneumoniae, Streptococcus
agalactiae (GBS), Staphylococcus aureus, Streptococcus pyogenes (GAS), Enterobacter-
iaceae, Enterococcus faecalis, Enterococcus faecium, Ureaplasma parvum, Ureaplasma
urealyticum, Mycoplasma hominis and Mycoplasma genitalium, a 16S rRNA gene broad-
range PCR and a multiplexed PCR for Candida spp.
Results
Two-hundred and eight samples were processed. In five of those samples, organisms were
detected by conventional culture; all of those were also identified by PCR. PCR detected
bacteria in 91 (45%) of the 203 samples that did not show bacterial growth in culture. S.
aureus, Enterobacteriaceae and S. pneumoniae were the most frequently detected patho-
gens. A higher bacterial load detected by PCR was correlated positively with the number of
clinical signs at presentation.
Conclusion
Real-time PCR has the potential to be a valuable additional tool for the diagnosis of neonatal
sepsis.
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Introduction
Treatment for presumed sepsis is common in the neonatal period. Early onset sepsis (EOS) is
defined as infection occurring within the first 48–72 hours of life, most often acquired shortly
before or during delivery. The most common causal pathogen in the UK is Streptococcus aga-
lactiae (GBS), followed by Escherichia coli [1].
Blood cultures remain the gold standard for diagnosing neonatal sepsis, in spite of being
positive in a minority of cases with suspected sepsis, especially EOS [2, 3]. False negative blood
cultures may occur as a result of small volumes of blood obtained, low levels of bacteraemia,
use of prior (intrapartum) antibiotics or fastidious bacteria, fungi or viruses. Because a nega-
tive blood culture cannot exclude infection, antibiotic therapy is often continued beyond 48
hours despite negative blood cultures, especially, but not always, when there are clinical signs
and laboratory markers consistent with infection [4]. This increases antibiotic usage, which in
turn increases the risk of development of antibiotic resistant pathogens [5–8], as well as poten-
tial immune dysregulation in childhood, as a result of disruptions in nascent gut microbiome
[9]. Moreover, prolonged empirical antibiotic therapy (>5 days) among neonates <1000g
birth weight has been associated with an increased risk of death and necrotizing enterocolitis
[10].
In an era of increasing antibiotic stewardship, improved diagnostic reliability is essential for
limiting antibiotic usage. PCR-based techniques have the potential to improve diagnostic
reliability.
In this study, whole blood samples of neonates with suspected EOS on the basis of risk and
/or clinical indicators were processed by PCR methods including multiplexed, real-time PCR
assays targeting a panel of bacterial pathogens, broad range bacterial 16S rRNA gene PCR and
a multiplexed real-time PCR assay targeting Candida spp, in order to identify pathogens not
detected by routine culture methods.
Materials and methods
Subjects
Neonates less than 72 hours of age undergoing investigation for presumed sepsis were
recruited in three tertiary centres, following written parental consent. All neonates were
inborn, evaluated either in the neonatal or maternity ward. The first-choice antibiotic regimen
for empirical treatment of suspected EOS recommended by the National Institute for Health a
and Care Excellence is bencylpenicillin with gentamicin. Investigations for sepsis could occur
as a result of compatible clinical or laboratory signs or because of perceived risk factors in an
otherwise asymptomatic neonate.
Sample collection
Whole blood (0.5–1 ml) was collected in an EDTA bottle at the time of venipuncture when
performing the initial sepsis screen or within 24 hours of initial evaluation. Confirmed infec-
tion was defined as a positive bacterial blood culture in the presence of clinical signs and symp-
toms of infection.
Culture methods
Whole blood was collected using aseptic technique and cultured in BacT Alert Pediatric cul-
ture bottles for five days. As this was part of routine medical care of the patients and not the
study procedure, blood volume collected was not recorded.
PCR for the diagnosis of neonatal sepsis
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DNA extraction
Total DNA was extracted from 100μl of whole blood using the Roche MagNA PURE auto-
mated extraction instrument (Roche Diagnostics, West Sussex, UK). DNA extracts were stored
at -70˚C.
Bacterial multiplex PCR
Targets were bacteria known to account for the majority of EOS in developed countries [1,
11]. All extracts were processed by a panel of six bacterial multiplexed real-time PCR assays
targeting S. pneumoniae, S. agalactiae (GBS), S. aureus, S. pyogenes (GAS) / Streptococcus pyo-
genes, Enterobacteriaceae, Enterococcus faecalis, Enterococcus faecium, Ureaplasma parvum,
Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium (see Table 1). The
individual pathogen specific PCRs had been developed and evaluated previously [12–20]. For
the purpose of this study, the efficiency of the reaction when a primer is combined with others
was compared to the efficiency of the primer functioning on its own. Serial ten-fold dilutions
of a known concentration of target DNA were amplified as monoplex and to test for inhibi-
tion, the resulting Ct values were compared to those required for detection of the same amount
of target DNA in a triplex PCR. The reaction contained 13 μl of QuantiFast Multiplex master-
mix (Qiagen, Crawley, United Kingdom) and 7μl of DNA extract. Primer and probes used for
each reaction and their concentrations are shown in Table 1.
A positive internal control was added to every sample prior to extraction to control for
extraction efficiency and PCR inhibition. Every batch of samples tested included a negative
and positive control. Thermocycling was performed on the BioRad CFX 96 Real Time PCR
detection system (BioRad, Hertfordshire, UK) as follows: 5 minutes at 95˚C followed by 45
cycles of 15 seconds at 95˚C and 30 seconds at 60˚C.
A positive PCR signal was defined as quantification cycle (Cq)�40. Amplicons of samples
testing positive for Enterobactericeae were sequenced. Only samples yielding sequences that
could be identified to at least genus level using BLAST analysis against the Genbank database
were considered true positives.
16S rRNA gene PCR
Samples testing negative by bacterial multiplex PCR were processed by 16S rRNA gene PCR
using Power SYBR1 Green PCR Master Mix (Life Technologies, Paisley, UK). 5μl extracted
DNA was added to 12.5 μl Master mix, 0.1 μM of forward primer 16SFa (GCTCAGATT-
GAACGCTGG), 0.05 μM each of forward primer 16SFb1 and 16SFb2 (GCTCAGGAC-
GAACGCTGG and GCTCAGGATGAACGCTGG), 0.1 μM of reverse primer 16SR
(ACTGCTGCCTCCCGTA) [21] and 6.5μl molecular grade nuclease free water (Qiagen). This
primer pair covers the highly variable region V1-V2, amplifying a PCR product of approxi-
mately 320 base pairs. This primer pair had been developed for routine use in Great Ormond
Street Children Hospital clinical microbiology laboratory for diagnosis of culture negative
samples and identification of unknown isolates [21].
Candida multiplex PCR
Samples from which no bacterial pathogen was identified were further processed by a multi-
plexed real-time PCR targeting C. albicans, C. glabrata, C. krusei, C. dubliniensis, C. famata, C.
guilliermondii, C. parapsilosis and C. tropicalis [22]. The reaction contained 13 μl of QuantiFast
Multiplex mastermix (Qiagen), 7μl of extracted DNA, and 0.1 each of primers (cand-CR1;
cand–CR5) and 0.1 uM probe (cand-rox) (Table 1).
PCR for the diagnosis of neonatal sepsis
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Sequencing
Table 1.
Organism Oligo Name Sequence 5’ to 3’ Target
gene
Conc
(μM)
Reference
Bacterial PCR
Streptococcus pneumoniae LytA-F ACG CAA TCT AGC AGA TGA AGC LytA 0.2 Harris 2008 [12]
LytA-R TGT TTG GTT GGT TAT TCG TGC 0.2
LytA-Probe FAM-TTT GCC GAA AAC GCT TGA TAC AGG G- BHQ1 0.2
Streptococcus agalactiae (GBS) GBS-F ATC CTG AGA CAA CAC TGA CA Sip 0.2 Berseng 2007 [13]
GBS-R TTG CTG GTG TTT CTA TTT TCA 0.2
GBS-Probe JOE-ATC AGA AGA GTC ATA CTG CYA CTT C-BHQ1 0.2 Tann 2014 [14]
Staphylococcus aureus SA _Forward GTA GAT TGG GCA ATT ACA TTT TGG AGG Coa 0.15 Sabet 2006 [15]
SA _Reverse CGC ATC TGC TTT GTT ATC CCA TGT A 0.15
SA _Probe FAM- TAG GCG CAT TAG CAG TTG CAT C-BHQ1 0.15
Streptococcus pyogenes GAS_Forward TGG ATG TGG TTG CAG GTT TAG AC csrR 0.3 Tann 2014 [14]
GAS_ Reverse CGG GCA AGT AGT TCT TCA ATG G 0.3
GAS_Probe JOE-CGG TGC AGA CGA CTA TAT TGT TAA
ACC-BHQ1
0.2
Enterobacteriaceae family Ent_ Forward ACCTGGGTACWACCAACTCTTGTGT dnaK 0.3 Tann 2014 [14]
Ent_Reverse GTCACTGCCTGACGTTTAGC 0.3
Ent_Probe JOE-AGGATGGTGAAACTCTGGTWGGTCAGCC-BHQ1 0.3
Enterococcus faecium Fium_Forward TTC TTT GCT TTA TCC GAT GT ddlfm 0.2 Mohn 2004 [16]
Fium_Reverse CGG TTT TCT GCT TTT GTA AT 0.2
Fium_Probe FAM- ACT AGA ACC CAT ATT CGC C-BHQ1 0.15
Enterococcus faecalis Falis_Forward CGCTTCTTTCCTCCCGAGT 16S 0.24 Santo Domingo
2003 [17]Falis_Reverse GCCATGCGGCATAAACTG 0.24
Falis_Probe Hex-GAGGAGTGGCGGACG-BHQ1 0.15
Ureaplasma parvum UPure F CAT TGA TGT TGC ACA AGG AGA AA ure 0.24 Cao 2009 [18]
UPure R TTA GCA CCA ACA TAA GGA GCT AAA TC 0.24
UPure Probe FAM-TTG ACC ACC CTT ACG AG-BHQ1 0.15
Ureaplasma urealyticum UUre_F ATC GAC GTT GCC CAA GGG GA ure 0.24 Cao 2009 [18]
UUre R TTA GCA CCA ACA TAA GGA GCT AAA TC 0.24
UUre Probe HEX-TTG TCC GCC TTT ACG AG–BHQ1 0.15
Mycoplasma genitalium MgPa-355F GAGAAATACCTTGATGGTCAGCAA G-37T 0.25 Jensen 2004 [19]
MgPa-432R GTTAATATCATATAAAGCTCTACCGTTGTTATC 0.25
MgPa-380 FAM-ACTTTGCAATCAGAAGGT-MGB 0.15
Mycoplasma hominis MHyidCfwd TCA CTA AAC CGG GTA TTT TCT AAC AA yidC 0.25 Ferandon 2010
[20]MHyidCrev TTG GCA TAT ATT GCG ATA GTG CTT 0.25
MHyidC HEX- CTA CCA ATA ATT TTA ATA TCT GTC GGT
ATG-BHQ1
0.15
Internal positive control (added in A,
B, C, D, E and F)
IPC _F GGA CAC TAT GCC CCT CCT TAG A mus 0.1 Tann 2014 [14]
IPC _R AGC TCC AAA CTC CGT CTC TGT AA 0.1
IPC _Probe CY5-TTG GGA ACA AAA CAC CCA TGG AAG GA-BHQ3 0.1
Candida PCR
(Continued)
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For positive Enterobacteriaceae and 16S rRNA gene PCR assays the resulting amplicon was
sequenced using Big-dye 3.1 sequencing kit (Thermo Fisher, Paisley, UK) and run on a 3130
Genetic analyser (ThermoFisher).
Clinical observations
Clinical signs to be recorded at enrolment were specified in the study proforma and included
fever, hypothermia, respiratory distress, grunting, nasal flare, tachypnoea, recession/retraction,
hypoxia, tachycardia, bradycardia, poor perfusion, hypotension, poor feeding, irritability,
hypotonia, convulsions, apnoea, lethargy, metabolic acidosis, glucose imbalance, high white
cell count (WCC), neutrophil count and raised C-reactive protein (CRP)
Fever was defined as axillary / central temperature of�38˚C on one occasion or�37.5˚C
on two occasions separated by at least one hour, A raised CRP was defined as> 10mg/L, a
raised WCC as (> 20 000 x109 cells/L), glucose imbalance as�2.2 /�10mmol/l for 4 hours in
spite of corrective measures and metabolic acidosis as base excess (BE)�-8 mmol/L over 4
hours in spite of corrective measures.
To correlate the number of clinical signs and laboratory markers with bacterial load sam-
ples detected by qPCR, samples were grouped by their PCR signal into strongly positive (< 35
Cq), positive (35–38 Cq), weakly positive (38–40 Cq) and negative (>40 Cq or no signal) as is
routine in clinical practice. In samples positive for multiple bacteria only the strongest signal
was taken into account. The groups were compared using a two-tailed Fisher’s exact test
(GraphPad Software, La Jolla California, USA).
Table 1. (Continued)
Organism Oligo Name Sequence 5’ to 3’ Target
gene
Conc
(μM)
Reference
Candida spp. cand-CR1
(forward)
CGGGTGGGAAATTCGGT RPR1 0.1 Innings 2007 [22]
cand-CR5
(reverse)
CAATGATCGGTATCGGGT 0.1
cand-ROX
(reverse)
ROX- TTCGCATATTgCAcTAAaYaGa–BHQ2� 0.1
C. glabrata gla-CR3
(forward)
RGCAACGGCTGGGAAT 0.1
cand-CR5
(reverse)
CAATGATCGGTATCGGGT 0.1
gla-JOE (reverse) JOE-TAAAGCCTCACCACGATTTTGACAC- BHQ1 0.1
C. krusei cand-CR1
(forward)
CGGGTGGGAAATTCGGT 0.1
krus-CR5
(reverse)
TAGTGATCGGTATCGAGTT 0.1
krus-Cy5
(reverse)
Cy5- CCAAAGTTGTACAAGCAAGTACCA- BHQ3 0.1
C. albicans cand-CR1
(forward)
CGGGTGGGAAATTCGGT 0.1
cand-CR5
(reverse)
CAATGATCGGTATCGGGT 0.1
alb-FAM
(reverse)
Fam- CAGCTTGTAGTAAAGAATTACTCAC-BHQ1 0.1
Primers and probes as used in the PCR panel. Each PCR was run as a triplex PCR with an internal positive control. The table lists their sequence, including the probes’
fluorophores (FAM, JOE, CY5) and quenchers (BHQ1 and BHQ2), the target gene, melt temperature (Tm) and guanine cytosine content (GC).
https://doi.org/10.1371/journal.pone.0226817.t001
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Results
Clinical observations
Blood samples from 208 neonates were analyzed. Fifty-nine (28%) were preterm (< 37 weeks
gestational age), with 12 (6%) very preterm (28 to< 32 weeks) and 11 (5%) extremely preterm
(< 28 weeks). Sixty mothers had received intrapartum antibiotics. One or more clinical signs
were observed in 147 (71%) of all neonates: 17 (6 signs), 15 (5 signs), 19 (4 signs), 30 (3 signs),
36 (2 signs) and 30 (1 sign). The most commonly occurring signs were respiratory: tachyp-
noea, respiratory distress, grunting or recession. Sixty-five (31%) neonates had an elevated
CRP. Of those, 27 neonates had an elevated CRP on initial screen and also on the following
day, whilst 26 neonates had an elevated CRP only on the second day. A repeat CRP was not
performed in all neonates; in 107 (51%) CRP results were only available from the day of the
initial screen. An elevated white cell count was reported in 46 neonates (22%). All neonates
survived to hospital discharge.
Culture positivity
Samples from 5 neonates were culture positive and all were also positive by PCR for the same
organism (four GBS and one E. faecalis). The remaining 203 samples were culture negative
after five days of incubation and PCR detected an organism in 91 (45%) of these. The five
infants ranged in gestation from 39 to 42 weeks. One baby had six clinical signs, two five and
the remaining two had four clinical signs, ranging from fever, grunting, tachypnoea, recession,
hypoxia, irritability, hypotonia and convulsions to glucose imbalance. In one of the five babies,
the mother had received antenatal antibiotics.
Bacterial PCR
Samples from 208 neonates were tested by the bacterial real-time PCR panel and samples from
96 neonates tested positive for at least one bacterial species. Of those neonates with a positive
bacterial PCR, 22 of 96 (23%) were born prematurely and 25 of their mothers (26%) had
received intrapartum antibiotics. Clinical signs and/or laboratory results indicative of sepsis
were present in 80 (83%); 69 (72%) had clinical signs; 34 (35%) had an elevated CRP and 23
(24%) had an abnormal white cell count. 18 samples tested positive for more than one bacte-
rium. Seven of the 29 with no recorded clinical signs had an elevated CRP (one of them also
had an elevated WCC), a further six had an elevated WCC.
Of those neonates with a negative culture and a negative bacterial PCR (n = 112), 87 (77%)
had clinical signs consistent with sepsis. Of the 32 with no clinical signs, seven had an elevated
CRP and/or WCC.
Newborns with a positive PCR result did not differ significantly from those with a negative
PCR result in term of clinical signs, laboratory markers prematurity or maternal antibiotic
with the exception of hypothermia, which was significantly more common amongst infants
with a positive PCR result (see Table 2).
The distribution of bacterial species detected by multiplex PCR is described in Fig 1 and
Table 3. The most frequently detected organisms were S. aureus in 28 samples (24%), Entero-
bacteriaceae in 23 samples (20%), S. pneumoniae in 21 samples (18%) and GBS in 17 samples
(15%).
Correlation between clinical signs / laboratory markers and PCR results. Table 4
describes the association between clinical and laboratory features of infants with presumed
sepsis and their PCR results. Neonates with strongly positive signals (<35 Cq) were likely to
have more clinical signs than those with positive, weak or no signals. This was particularly so
PCR for the diagnosis of neonatal sepsis
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for strongly positive vs. positive signals for those with� 1 sign (p = 0.005) and� 5 signs
(p = 0.009). Associations between abnormal CRP and WCC values with PCR results were less
apparent.
Twenty-seven samples tested positive for Enterobacteriaceae by PCR and the resulting
amplicons were sequenced. In 23 of these a single organism was identified by BLAST analysis
to at least genus level whilst in the remaining four, sequence data appeared mixed or no data
was produced. E. coli and Enterobacter spp. were detected most frequently (see Table 5).
In 18/117 (15%) of positive samples more than one pathogen was detected; 15 samples
tested positive for 2 bacterial species and 1 sample each tested positive for 3 and 4 bacterial spe-
cies. Table 6 shows the combinations of bacteria found together.
16S rRNA gene PCR
In total 108 samples were processed by 16S rRNA gene PCR; these included samples positive
for Enterobacteriacae for which sequence-based identification could not be achieved.
Of these, 13 were 16S rRNA gene PCR positive and sequencing of the PCR product identi-
fied Streptococcus spp. (mitis group) in two cases and Propionibacterium spp. in three cases. In
four cases, waterborne organisms (Pseudomonas spp./ P. fluorescens), likely to be contami-
nants, were identified; the remaining four cases showed a mixed or no sequence data.
Candida multiplex PCR
Of the 60 samples that were negative by every other test, 36 had sufficient residual extract for
testing with the Candida multiplexed PCR. All tested negative.
Discussion
A large number of neonates are treated with antibiotics for presumed infection despite having
no organism detected in their blood cultures.
A recent metanalysis on molecular assays for the diagnosis of sepsis in neonates reports a
mean sensitivity of 0.90 and specificity of 0.93. The authors conclude that molecular assays are
feasible in neonates and due to their rapid detection times compared to blood cultures may
impact on early diagnosis and treatment [23].
This study investigated blood samples of neonates with suspected EOS and demonstrated
that a panel of multiplexed real-time PCR assays could identify pathogens in 45% of cases
where blood cultures were negative as well as correctly identifying a pathogen in 100% of cases
Table 2.
PCR +ve % (N) PCR -ve % (N) p-value
Prematurity 23 (22) 32 (36) 0.25
Maternal antibiotics 26 (25) 33 (37) 0.47
Total symptomatic 83 (80) 77 (87) 0.48
Tachypnoea 43 (41) 40 (44) 0.67
Hypothermia 31 (30) 2 (2) 0.00026
Recession/retraction 25 (24) 28 (31) 0.74
Grunting 22 (21) 29 (33) 0.94
Fever 17 (16) 17 (19) 0.97
Nasal flare 11 (11) 13 (14) 0.90
Most common signs and clinical features of newborns testing PCR positive vs negative.
https://doi.org/10.1371/journal.pone.0226817.t002
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Fig 1. Distribution of bacteria detected by specific bacterial PCR in 96 samples of neonates with suspected EOS.
https://doi.org/10.1371/journal.pone.0226817.g001
Table 3.
Pathogen <35 Cq
(strongly positive)
35–38 Cq
(positive)
38–40 Cq
(weakly positive)
% (N)
S. aureus 4 17 7 24 (28)
Enterobacteriaceae 5 18 0 20 (23)
S. pneumoniae 1 16 4 18 (21)
Streptococcus agalactiae 10 5 2 15 (17)
Enterococcus spp.1 4 7 2 11 (13)
GAS 2 4 2 7 (8)
Ureaplasma spp. 2 1 3 1 4 (5)
M. hominis 1 1 0 2 (2)
Total [% (n)] 24 (28) 60 (71) 15 (18) 100 (117)
Distribution of bacteria detected by multiplex PCR by Cq range. The total number of bacteria (117) is higher than the number of samples positive for multiplex PCR
(96) as 18 samples contained multiple bacteria.
1 10 E. faecalis, 3 E. faecium.
2 4 U. parvum, 1 U. urealyticum.
https://doi.org/10.1371/journal.pone.0226817.t003
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where blood cultures were positive. Furthermore, we have shown that higher bacterial load
appears to correlate with the number of clinical signs at presentation. No significant associa-
tion was detected between an abnormal CRP and PCR results, however this study was con-
ducted before current NICE guidelines were implemented, which recommend to perform a
repeat CRP at 18–24 hours [24]. A CRP value from a sample obtained too early in life could
represent a false negative. Only half of all neonates had results of a second CRP available, there-
fore a complete evaluation of this association was not possible.
The samples of this study were subject to some limitations. Extraction was performed on a
robotic platform, a technique shown to be inferior to manual extraction in terms of DNA yield
and purity [25]. Extracts were stored at -70˚ Celsius until final processing. Storage conditions
can have significant impact on DNA integrity [26] and extracts are especially vulnerable to
repeated freeze/thaw cycles [27]. A number of samples were subjected to repetitions of the dif-
ferent processing steps; potentially increased contamination and/or degradation could have
occurred each time.
Some members of the Enterobacteriaceae family are ubiquitous skin and bowel commensals
and environmental contaminants. The high number of these bacteria detected raises suspicion
of contamination and amongst samples positive for Enterobacteriaceae only those yielding a
Table 4.
Cq <35
% (N)
<35 vs 35–38
p-value
Cq = 35–38
% (N)
35–38 vs 38–40
p-value
Cq = 38–40
% (N)
38–40 vs >40
p-value
Laboratory markers
CRP 50 (12) 0.08 29 (17) 0.74 36 (5) 0.34
WCC 25 (6) 1.00 27 (16) 0.16 7 (1) 0.30
Clinical signs
�1 sign 88 (21) 0.005 54 (32) 0.37 71 (10) 1
�2 signs 75 (18) 0.02 46 (27) 1.00 43 (6) 0.27
�3 signs 60 (14) 0.05 32(19) 1.00 29 (4) 0.56
� 4 signs 42 (10) 0.19 25 (15) 1.00 21 (3) 1.00
� 5 signs 38 (9) 0.009 10 (6) 0.64 14 (2) 1.00
� 6 signs 13 (3) 0.35 5 (3) 0.24 14 (2) 0.35
Correlation between clinical signs / laboratory markers and PCR results. This table shows the percentage (number) of infants with samples in each Cq range and
number of clinical signs (1 to 6) as well as percentage (number) of infants with abnormal laboratory markers and the p-values as calculated by two-tailed Fisher’s exact
test.
https://doi.org/10.1371/journal.pone.0226817.t004
Table 5.
Amplicon sequencing results for pan-Enterobacteriacae PCR positive samples N
E.coli 7
Enterobacter spp. 5
Enterobacter spp./Citrobacter spp. 3
Klebsiella spp. 2
Klebsiella spp./E.coli 1
Klebsiella spp./ Enterobacter 1
Citrobacter spp. 1
Citrobacter spp./Pantoea spp. 2
Serratia spp. 1
Total 23
Enterobacteriacae identified by Sanger sequencing of the Enterobacteriaceae dnaK PCR product from 23 samples.
https://doi.org/10.1371/journal.pone.0226817.t005
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sequence identifiable to genus level by BLAST analysis were therefore reported. This was based
on the previous observation that contamination usually occurs with multiple species from this
family (K. Harris–unpublished data).
Overall, S. aureus was the most frequently detected organism (23%) and even though gener-
ally considered as representing true infection [28], early infant colonization is not uncommon
[29] and thus skin contamination may also have contributed to the high number found in this
study.
Nonetheless, with cautious interpretation of these data, this study has notable findings.
Most significantly, a large proportion of samples (45%) tested positive by bacterial multiplex
PCR. In contrast, a pathogen was identified by routine culture methods in only 2.4%.
S. pneumoniae was present in 18% of all positive samples, more frequent than GBS (15%).
S. pneumoniae is a relatively rare pathogen in neonatal sepsis (1–11%) [30], and a rare cause of
neonatal skin colonization, yet when it occurs, the course of the disease has been reported to
be more severe, particularly in EOS [31]. Early onset S. pneumoniae infection is often associ-
ated with maternal vaginal colonization or disease [32–34]. The bacterium can be difficult to
culture, particularly following administration of intrapartum antibiotics [12, 35], which could
lead to under diagnosis based on blood culture data. Thus this study might reflect a more accu-
rate representation of its prevalence in newborn sepsis.
Enterococcus spp. were detected in 11% of all PCR positive cases. Of concern is that only in
one case was it isolated by blood culture, despite there being no general awareness of difficul-
ties in culturing these bacteria. An increase of Enterococcus spp. in neonatal units has been
reported [36] and concerns regarding the spread of vancomycin-resistant strains has prompted
many units to adopt surveillance and control measures [37, 38].
GAS is considered a neonatal pathogen of the past [39]. However, PCR methods detected
GAS in eight samples (7%). Similarly, Ureaplasma spp. and Mycoplasma spp., which have been
associated with premature birth and infection [40], are rarely detected in cultures due to their
fastidious growth requirements. PCR was able to identify these organisms in seven cases.
Increased detection of these pathogens, together with further evidence of their significance,
could have implications for treatment regimens.
A large number of samples (15%) tested positive for multiple bacteria. The proportion of
mixed infections reported by culture based studies range from 1–19%. [1, 41–45]. These
Table 6.
Polymicrobial infection No
S. pneumoniae + S. aureus 5
S. pneumoniae + GBS 2
S. aureus + Enterobacteriaceae 2
S. aureus + Enterococcus spp. 2
S.pneumoniae + S. pyogenes 1
S.pneumoniae + Enterobacteriaceae 1
GBS + Enterobacteriaceae 1
U. parvum + S. aureus 1
GBS + GAS 1
S. pneumoniae + S. agalactiae + E. faecalis 1
S. pneumoniae + S. aureus + Enterococcus spp. + S. agalactiae 1
Total 18
Combinations of bacteria found in 18 samples positive for more than one organism and their numbers.
https://doi.org/10.1371/journal.pone.0226817.t006
PCR for the diagnosis of neonatal sepsis
PLOS ONE | https://doi.org/10.1371/journal.pone.0226817 January 24, 2020 10 / 14
results, to some extent, may represent contamination, as discussed above. However, polymi-
crobial bloodstream infections are important, as they are associated with a more than 3-fold
increase in mortality, increase in duration of infection and greater severity of illness [45,46].
The correlation between the number of clinical signs and PCR positivity is a novel finding
and provides some confidence in the relevance of these tests. Clinical signs and laboratory
markers are known to be subjective and non-specific in the context of neonatal sepsis [47] but
have not been validated using PCR as gold standard. The only individual sign to show signifi-
cance between PCR positive and negative cases was hypothermia, strengthening its value as a
marker of sepsis. Clinical signs of sepsis to evaluate sepsis in this study are therefore also non-
specific and included signs of respiratory distress which may reflect different pathologies par-
ticularly in the premature infant. Our data suggests that use of PCR could provide insight into
the value of different (and the number of) clinical signs and biomarkers in diagnosing neonatal
sepsis.
Conclusions
Molecular diagnostic methods are capable of detecting a large number of pathogens in samples
from neonates with suspected sepsis. False positive results can have significant implications for
clinical practice as well as research. Therefore strict procedures for sample collection and pro-
cessing to avoid contamination need to be applied, as well as cautious interpretation of results
particularly when organisms associated with skin or environmental contamination are
detected. In this study, in contrast to many studies based on culture, GBS was not the most
commonly detected pathogen in early onset sepsis. Indeed, S. pneumoniae may be a more
important pathogen in EOS than the existing literature indicates. Polymicrobial sepsis might
also occur more often than currently estimated. As an additional diagnostic tool, PCR methods
have the potential to increase diagnostic reliability of causal pathogens for neonatal sepsis.
This could facilitate a reduction in unnecessary broad spectrum antibiotic usage, and target
treatment to improve outcomes, as well as limit the development of antibiotic resistance.
Future studies could also explore associations of clinical signs and PCR positivity from differ-
ent organisms.
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